OGX-427 inhibits tumor progression and enhances gemcitabine chemotherapy in pancreatic cancer
Despite many advances in oncology, almost all patients with pancreatic cancer (PC) die of the disease. Molecularly targeted agents are offering hope for their potential role in helping translate the improved activity of combination chemotherapy into improved survival. Heat shock protein 27 (Hsp27) i...
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
Nature Publishing Group
2011
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3219088/ |